BioScrip to Report Second Quarter 2008 Earnings on July 31

Thu. July 17, 2008; Posted: 04:52 PM

7 Stocks You Need To Know For Tomorrow -- Free Newsletter

ELMSFORD, N.Y., Jul 17, 2008 (BUSINESS WIRE) -- BIOS | Quote | Chart | News | PowerRating -- BioScrip, Inc. (Nasdaq: BIOS | Quote | Chart | News | PowerRating) today announced that it will host a conference call at 10:00 a.m. ET on Thursday, July 31, 2008, to discuss its second quarter operating results for the period ended June 30, 2008. BioScrip will issue a press release announcing the operating results before the market opens on July 31, 2008. Interested parties may participate in the conference call by dialing 888-214-7562 (US), or 415-537-1802 (international), 5-10 minutes prior to the start of the call. A replay of the conference call will be available from 12:00 p.m. ET on July 31, through 12:00 p.m. ET on August 6, by dialing 800-633-8284 (US), or 402-977-9140 (international) and entering reservation #21389016. An audio webcast and archive of the conference call will also be available under the investor relations section of the BioScrip website, www.bioscrip.com.

About BioScrip, Inc.

BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS | Quote | Chart | News | PowerRating) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex healthcare conditions.

SOURCE: BioScrip, Inc.

BioScrip, Inc. Craig Allison, 914-460-1636 Director, Corporate Communications callison@BioScrip.com or In-Site Communications Lisa M. Wilson, 917-543-9932 lwilson@insitecony.com

For full details for BIOS click here.

Morning Coffee with TradingMarkets -- Free Newsletter

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.